Fgure 3. Molecular genetic report confirming THS resistance via THRB
gene.

The diagnosis was explained to the patient and levothyroxine dose was
reduced gradually to maintain the lowest dose that is sufficient to
prevent symptoms with subsequent follow up to depend on T4 level and the
patient symptoms not on TSH level.